Orally active, antimycotic allylamine related to naftifine, q.v. Specific inhibitor of squalene epoxidase, a key enzyme in fungal ergosterol biosynthesis. Prepn: A. Stütz, EP 24587; idem, US 4755534 (1981, 1988 both to Sandoz); A. Stütz, G. Petranyi, J. Med. Chem. 27, 1539 (1984). Mode of action: G. Petranyi et al., Science 224, 1239 (1984); N. S. Ryder, Antimicrob. Agents Chemother. 27, 252 (1985). In vitro antifungal activity: S. Shadomy et al., Sabouraudia 23, 125 (1985). CE determn in pharmaceutical formulations: P. Mikus et al., Talanta 65, 1031 (2005). Symposium on pharmacology and clinical trials: J. Am. Acad. Dermatol. 23, Suppl., 775-812 (1990). Clinical trial as systemic treatment of toenail onychomycosis: E. G. V. Evans et al., Br. Med. J. 318, 1031 (1999); A. Tavkkol et al., Am. J. Geriatr. Pharmacother. 4, 1 (2006).
Antifungal.
Antifungal (Synthetic); Allylamines